Skip to main content
HemaSphere logoLink to HemaSphere
. 2022 Feb 23;6(3):e703. doi: 10.1097/HS9.0000000000000703

Correction Notice: Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party

PMCID: PMC8869616  PMID: 35224454

Since the publication of the article entitled “Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party” (HemaSphere. 2022;6(1):e676), the authors have requested a referencing correction. For Table 1, the correct references are 12-16. This has now been adjusted.

The changes have been made online: https://journals.lww.com/hemasphere/Fulltext/2022/01000/Technical_Aspects_of_Flow_Cytometry_based.5.aspx


Articles from HemaSphere are provided here courtesy of Wiley

RESOURCES